Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Histogen Inc. (HSTO)
OTHER OTC:HSTO
Holding HSTO?
Track your performance easily
HSTO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.05 - $0.93
Previous Close$0.22
Volume1.21K
Average Volume (3M)1.52K
Market Cap
$929.11K
Enterprise Value-$4.70M
Total Cash (Recent Filing)$4.60M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.53
Next Earnings
May 09, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.90
Shares Outstanding4,271,759
10 Day Avg. Volume315
30 Day Avg. Volume1,517
Standard Deviation0.22
R-Squared0.08
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)0.17
Price to Sales (P/S)48.90
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-247.52
Enterprise Value/Gross Profit-1.25
Enterprise Value/Ebitda0.38
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Histogen News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HSTO FAQ
What was Histogen Inc.’s price range in the past 12 months?
Histogen Inc. lowest stock price was $0.05 and its highest was $0.93 in the past 12 months.
What is Histogen Inc.’s market cap?
Currently, no data Available
When is Histogen Inc.’s upcoming earnings report date?
Histogen Inc.’s upcoming earnings report date is May 09, 2024 which is 134 days ago.
How were Histogen Inc.’s earnings last quarter?
Currently, no data Available
Is Histogen Inc. overvalued?
According to Wall Street analysts Histogen Inc.’s price is currently Overvalued.
Does Histogen Inc. pay dividends?
Histogen Inc. does not currently pay dividends.
What is Histogen Inc.’s EPS estimate?
Histogen Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Histogen Inc. have?
Histogen Inc. has 4,271,759 shares outstanding.
What happened to Histogen Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Histogen Inc.?
Currently, no hedge funds are holding shares in HSTO
---
Histogen Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Histogen Inc.
Conatus Pharmaceuticals, Inc. is a biotechnology company, which engages in the development and commercialization of medicines for the treatment of liver diseases. It focuses in development of emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease, which reduce the activities of human caspases. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA.
---
Technical Analysis
---